**Core Concept**
The Vi polysaccharide vaccine is a type of conjugate vaccine used for the prevention of typhoid fever. It contains the capsular polysaccharide of *Salmonella Typhi* and is often administered to individuals traveling to or living in areas where typhoid fever is common.

**Why the Correct Answer is Right**
The Vi polysaccharide vaccine can be administered to individuals with a history of yellow fever vaccination, as well as those with hepatitis B vaccination. This is because the Vi polysaccharide vaccine does not contain live or attenuated pathogens, making it safe for individuals with weakened immune systems or those who have received other vaccinations. The vaccine works by stimulating the production of antibodies against the Vi capsular polysaccharide, which helps to protect against typhoid fever.

**Why Each Wrong Option is Incorrect**
* **Option B:** The Vi polysaccharide vaccine has few contraindications, as it is generally well-tolerated and safe for most individuals.
* **Option C:** The Vi polysaccharide vaccine has a good safety profile, with few serious systemic side effects reported. Common side effects include pain, redness, and swelling at the injection site.
* **Option D:** The Vi polysaccharide vaccine has a low risk of serious local side effects, such as anaphylaxis or abscess formation.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that the Vi polysaccharide vaccine is often recommended for individuals traveling to areas with high typhoid fever prevalence, particularly those visiting or working in areas with poor sanitation and hygiene.

**✓ Correct Answer: A. Can be given in patients with yellow fever and hepatitis B**